Prqr Stock Forecast Zacks

Get the latest proqr therapeutics n.v. This chart shows the closing price for prqr for the last year in relation to the current analyst high, average, and low pricetarget.

Periódico Metro (Reino Unido). Periódicos de Reino Unido

This has helped prqr to earn a zacks rank #1 (strong buy), further underscoring the company’s solid position.

Prqr stock forecast zacks. According to the issued ratings of 5 analysts in the last year, the consensus rating for proqr therapeutics stock is buy based on the current 5 buy ratings for prqr. Get the latest price and consensus chart for proqr therapeutics n.v. Proqr (prqr) came out with a quarterly loss of $0.29 per share versus the zacks consensus estimate of a loss of $0.26.

Prqr investment & stock information. Learn more on prqr's analyst rating history This compares to loss of $0.49 per share a year ago.

The average price target is $27.67, with a high forecast of $44.00 and a low forecast of $18.00. Last year's 2019 zacks top 10 stocks portfolio returned gains as high as +102.7%. Prqr need to pay close attention to the stock based on moves in the options market lately.

This suggests a possible upside of 358.7% from the stock's current price. The average price target represents a 237.40% upside from the last price of $8.20. You can see the complete list of today’s zacks #1 rank stocks here.

On average, they anticipate proqr therapeutics' stock price to reach $30.00 in the next year. That is because the oct 15, 2021 $5.00 call had some of the highest. The stock has a beta of 0.68 and surged 10.4% in the past month.

Proqr (prqr) came out with a quarterly loss of $0.21 per share versus the zacks consensus estimate of a loss of $0.39. Zacks top 10 stocks for 2020. Their forecasts range from $18.00 to $44.00.

Wall street stock market & finance report, prediction for the future: Agilent technologies stock forecast, a stock price prediction. Do the numbers hold clues to what lies ahead for the stock?

Price target in 14 days: (prqr) stock quote, history, news and other vital information to help you with your stock trading and investing. Want the latest recommendations from zacks investment research?

This compares to loss of $0.09 per share a year ago. Click to get this free report proqr therapeutics n.v. Investors in proqr therapeutics n.v.

Find the latest proqr therapeutics n.v. Prqr | complete proqr therapeutics n.v. Today, you can download 7 best stocks for the next 30 days.

Pin von Zack Viola auf firearms Star wars charaktere

PFC (Power Finance Corporation Limited) BUY ABOVE 98.5

Professional wrestler John Cena punches above his weight